Second Generation 18F-labeled Prostate-Specific Membrane Antigen (PSMA) Targeted Imaging Agent Found to be Highly Sensitive in Detecting Prostate Cancer

Culver City, CA (PRWEB) April 28, 2015 A first-in-human prostate cancer study released today in the Journal of Molecular Imaging and Biology showed initial safety, biodistribution, and dosimetry results with [18F]DCFPyL, a 2nd generation fluorine-18 labeled small-molecule PSMA inhibitor. The imaging biomarker has been developed at Johns Hopkins University in Baltimore, MD by study co-author, ...

Resolution Bioscience announces successful collaboration on a novel, non-invasive, targeted NGS test for lung cancer

Resolution Bioscience announces successful collaboration on a novel, non-invasive, targeted NGS test for lung cancer
Seattle, Washington (PRWEB) April 16, 2015 Dana-Farber Cancer Institute and its Belfer Institute for Applied Cancer Science and Resolution Bioscience, Inc. today announced the successful completion of a collaborative agreement to co-develop a novel, blood-based, clinic ready, Next Generation Sequencing (NGS) assay for non-small cell lung cancer (NSCLC). The collaboration is the first to demonstrate ...